Previous Article | Next Article ![]()
Journal of Virology, November 2000, p. 10796-10800, Vol. 74, No. 22
Lady Davis Institute for Medical Research and
McGill AIDS Centre, Jewish General Hospital,1
and Departments of Microbiology and
Immunology2 and
Medicine,3 McGill University,
Montreal, Quebec, Canada H3T 1E2
Received 11 May 2000/Accepted 4 August 2000
To study in vivo tRNA3Lys genomic placement
and the initiation step of reverse transcription in human
immunodeficiency virus type 1, total viral RNA isolated from either
wild-type or protease-negative (PR
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Roles of Pr55gag and NCp7 in
tRNA3Lys Genomic Placement and the Initiation Step
of Reverse Transcription in Human Immunodeficiency Virus
Type 1
) virus was used as the
source of primer tRNA3Lys/genomic RNA templates
in an in vitro reverse transcription assay. At low dCTP concentrations,
both the rate and extent of the first nucleotide incorporated into
tRNA3Lys, dCTP, were lower with PR
than
with wild-type total viral RNA. Transient in vitro exposure of either
type of primer/template RNA to NCp7 increased PR
dCTP
incorporation to wild-type levels but did not change the level of
wild-type dCTP incorporation. Exposure of either primer/template to
Pr55gag had no effect on initiation. These
results indicate that while Pr55gag is
sufficient for tRNA3Lys placement onto the genome,
exposure of this complex to mature NCp7 is required for optimum
tRNA3Lys placement and initiation of reverse transcription.
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research, Jewish General Hospital, Montreal,
Quebec, Canada H3T 1E2. Phone: (574) 340-8260. Fax: (574) 340-7502. E-mail: md26{at}musica.mcgill.ca.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|